Newsroom
Our latest developments
Orca Bio’s announcements and press releases
Orca Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
ViewOrca Bio Announces Orca-T® Phase 3 Data Published in Blood Demonstrate Significant Improvement in Survival Free from Chronic Graft versus Host Disease in Patients with Hematological Malignancies
ViewOrca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 67th American Society of Hematology Annual Meeting
ViewOrca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 67th American Society of Hematology Annual Meeting
ViewOrca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 67th American Society of Hematology Annual Meeting
ViewOrca Bio Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T® to Treat Hematological Malignancies
ViewOrca Bio Appoints Key Executives Including Steve Gavel as Chief Commercial Officer
View